City
Epaper

Mixture of anti-HIV drugs may be used to treat nCoV patients in India

By ANI | Updated: February 5, 2020 21:45 IST

In a significant move, the India Council of Medical Research (ICMR) has sought an emergency approval from Central Drug Control Orgsation (CDCSO) to use combination of anti-HIV drugs- 'Lopinavir and Ritonavir' tablets for the treatment of novel coronavirus (nCoV) patients in India, sources said.

Open in App

New Delhi [India], Feb 5 : In a significant move, the India Council of Medical Research (ICMR) has sought an emergency approval from Central Drug Control Orgsation (CDCSO) to use combination of anti-HIV drugs- 'Lopinavir and Ritonavir' tablets for the treatment of novel coronavirus (nCoV) patients in India, sources said.

This is only for restrictive use in the interest of the public health emergency.

"This decision has been taken in the recent meetings over the preparedness action on novel coronavirus. The Drugs Controller General of India (DCGI) has approved to use the combination of 'Lopinavir and Ritonavir' tablets for the treatment of nCoV patients for restrictive use in the interest of the public health emergency," sources told .

"As of now, there is no specific drug or vaccine to treat patients of coronavirus. Doctors across the globe are treating respiratory patients with supportive medication following the clinical guidelines of WHO," soured said.

According to the latest data by the Union Health Ministry, about 5123 people are under observation (community surveillance) across the country out of which 128 patients are hospitalised for suspected coronavirus infection.

So far in India, three medical students who returned to Kerala from China have confirmed positive for nCoV and all three patients are receiving treatment under quarantine in the state.

According to WHO, coronaviruses are large families of viruses, which cause illnesses to people and also circulate in mals including camels, cats, and bats. Rarely, mal coronaviruses can also evolve and infect people. The epicentre of the disease is mainland china's Wuhan City, which has infected over 15000 people and claimed more than 450 lives so far in China.

Meanwhile, a randomised controlled clinical trial is now underway in China to test the anti-HIV drugs' efficacy, according to a study published in the Lancet Journal on January 24.

Last week, the Central government brought back about 600 Indian nationals (most of them are students) from China amid the outbreak of novel coronavirus. Approximately, 248 people are quarantined at Army's Manesar camp, out of which 6 persons are sent to Base Hospital for further observation after they showed flu-like symptoms. Meanwhile, 406 persons have been quarantined at ITBP's isolation facility and 5 persons have been shifted to Safdarjung Hospital for medical care.

Also, as a part of preventive measures to stop the spread of the disease, the Central government has suspended all visas for travel to China, which were issued earlier.

( With inputs from ANI )

Open in App

Related Stories

NationalGST reforms: A welcome decision but not a new wisdom, says K'taka CM

InternationalIsraeli President presses Pope Leo XIV to help free Hamas hostages

NationalCommitted to resolving land-related issues: Telangana CM

InternationalMauritius Prime Minister to visit India from September 9 to 16

AurangabadWomen thieves strike Handloom export, six mangalsutras snatched

National Realted Stories

NationalBengal CEO to hold two key meetings in Kolkata on Sep 6 and Sep 8

NationalLooking forward to deepening bonds of friendship: PM Modi to Jamaican counterpart Andrew Holness

NationalRCA cancels elections in new dists, pushes ahead with Chomp Stadium project

NationalArunachal: 40 teachers awarded on Teachers’ Day

NationalHealth emergency to be declared in Andhra village hit by series of deaths